- Category
- Micro (2023-24)
- Udyam number
- UDYAM-RJ-17-0157297

Megs Pharmaceutical Limited
About Megs Pharmaceutical Limited
Data last updated:
Megs Pharmaceutical Limited is a public limited company based in Jaipur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 August 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U74999RJ2017PLC058722. Its GSTIN is 08AALCM2432Q1ZY (Rajasthan).
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Vrishdev Singh (Whole-Time Director) and Vijendra Singh Rathore.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P.No.D – 82 Flat No.S – 1 2nd Floor Manglam City Vill – Hathoj, Jaipur, Rajasthan, India – 302012.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.51 Cr, a growth of 51% compared to the previous year. For the same year it recorded a net profit of ₹6,953 (net margin 0%) and EBITDA of ₹3.2 Lakh (EBITDA margin 2.1%). Revenue has grown at a compounded annual rate (CAGR) of 81% over three years and 101% over five years.
As per MCA filings, the company has open charges of ₹38 Lakh on record.
Megs Pharmaceutical Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0157297). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Megs Pharmaceutical
Contact details
Megs Pharmaceutical Limited's registered office is in Jaipur, Rajasthan. Its e-mail address is in the company report.
- Email
- Registered AddressP.No.D – 82 Flat No.S – 1 2nd Floor Manglam City Vill – Hathoj, Jaipur, Rajasthan, India – 302012
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Megs Pharmaceutical Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Megs Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Megs Pharmaceutical Limited, buy the company report.
Financials of Megs Pharmaceutical Limited
FY 2025 filings availableMegs Pharmaceutical Limited reported revenue of ₹1.51 Cr (up 51% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 101% over five years, including 51% growth in the latest year. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.2 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6,953 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.1% | ||||
| Net Profit Margin | 0% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Megs Pharmaceutical Limited, buy the company report.
Board of directors of Megs Pharmaceutical Limited
Megs Pharmaceutical has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijendra Singh Rathore | Director | 26 Jan 2020 | 6 Years 9 Months | Current |
| Ray Singh | Director | 03 Aug 2017 | 9 Years 3 Months | Current |
| Vrishdev Singh Also directs: Yolo Dynamics Limited | Whole-Time Director | 03 Aug 2017 | 9 Years 3 Months | Current |
Peer comparison
Megs Pharmaceutical Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| C-Squared Pharma India Private Limited | ₹1.51 Cr (FY 2025) | 56.0% | Mumbai, Maharashtra, India | |||
| Alcuria Pharma Private Limited | ₹1.51 Cr (FY 2025) | 21.0% | Greater Noida, Uttar Pradesh, India | |||
| Chandramouli Industries Private Limited | ₹1.51 Cr (FY 2024) | -35.0% | Dhamdha, Chhattisgarh, India | |||
| Welora Lifesciences Private Limited | ₹1.51 Cr (FY 2019) | 842.0% | Chandigarh, India | |||
| Shree Baidyaraj Ayurved Bhawan Private Limited | ₹1.51 Cr (FY 2025) | 11.0% | New Delhi, Delhi, India | |||
| Megs Pharmaceutical Limitedthis company | ₹1.51 Cr (FY 2024) | ₹6,953 | 0% | 51.0% | Jaipur, Rajasthan, India | |
| Perduro (OPC) Private Limited | ₹1.5 Cr (FY 2023) | -85.0% | Chandigarh, India | |||
| Harishree Aromatics and Chemicals Private Limited | ₹1.5 Cr (FY 2022) | -28.0% | Mumbai, Maharashtra, India | |||
| Lenore Pharmaceuticals Private Limited | ₹1.5 Cr (FY 2024) | 31.0% | Lucknow, Uttar Pradesh, India | |||
| Medvina Healthcare Private Limited | ₹1.5 Cr (FY 2025) | 15.0% | Dehradun, Uttarakhand, India | |||
| Destiny Hi-Tech Medicines Private Limited | ₹1.5 Cr (FY 2021) | 13.0% | Kota, Rajasthan, India |
To see the full peer comparison of Megs Pharmaceutical Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Dec 2023 | 100889910 | Others | ₹25 Lakh | Open | |
| 31 Jan 2022 | 100538203 | Others | ₹2 Lakh | Open | |
| 01 Sep 2021 | 100476310 | Others | ₹10 Lakh | Open | |
| 01 Sep 2021 | 100479818 | Others | ₹1 Lakh | Open |
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Megs Pharmaceutical Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Megs Pharmaceutical Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Megs Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AALCM2432Q1ZY | Rajasthan | Active | 25 Jul 2018 |
To see the full GST registrations and return filing status of Megs Pharmaceutical Limited, buy the company report.
Recent activity
Megs Pharmaceutical Limited has 5 board changes on record since 2017: 3 appointments and 2 cessations. The latest: Santosh Singh ceased to be Whole-Time Director on 29 Jan 2020.
Frequently asked questions
Megs Pharmaceutical is an active public limited company based in Jaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 August 2017 (9+ years old) and is registered under CIN U74999RJ2017PLC058722.
Megs Pharmaceutical has 3 current directors:
- Vrishdev Singh - Whole-Time Director
- Vijendra Singh Rathore - Director
- Ray Singh - Director
The latest financial statements of Megs Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Megs Pharmaceutical is 08AALCM2432Q1ZY, registered in Rajasthan.
The CIN (Corporate Identification Number) of Megs Pharmaceutical is U74999RJ2017PLC058722. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Megs Pharmaceutical was incorporated on 03 August 2017, making it 9+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Megs Pharmaceutical by revenue are C-Squared Pharma India Private Limited, Alcuria Pharma Private Limited, Chandramouli Industries Private Limited, Welora Lifesciences Private Limited, Shree Baidyaraj Ayurved Bhawan Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Santosh Singh ceased to be Whole-Time Director on 29 Jan 2020. Vijendra Singh Rathore was appointed as Director on 26 Jan 2020. Pushpendra Singh Shekhawat ceased to be Managing Director on 04 Oct 2019. Megs Pharmaceutical has 5 board changes on record in total.
Yes, Megs Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-17-0157297).
The registered office of Megs Pharmaceutical is at P.No.D – 82 Flat No.S – 1 2nd Floor Manglam City Vill – Hathoj, Jaipur, Rajasthan, India – 302012.
Megs Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

